Covishield

India's Covid Boost? SII seeks DCGI approval for Covishield booster dose

India’s Covid Boost? SII seeks DCGI approval for Covishield booster dose

New Delhi: India is aggressively reaching its goal of vaccinating the entire adult population against Covid-19, the conversation is about a booster or additional doses to be administered. Take a step in this direction The Serum Institute of India (SII) has requested approval from the Drugs Controller General of India (DCGI) for Covishield as a …

India’s Covid Boost? SII seeks DCGI approval for Covishield booster dose Read More »

Find out how many countries have approved the Covishield vaccine so far – Check out the list here

New Delhi: Five vaccines have been approved in India, including Covaxin, Covishield, Sputnik V, Moderna, Johnson & Johnson’s Single Dose Vaccine, and the Zydus Cadila vaccine – ZyCoV-D. Among the vaccines administered in India, the Covishield vaccine is administered in the largest number. This vaccine was developed by Oxford-AstraZeneca together. In India, it is produced …

Find out how many countries have approved the Covishield vaccine so far – Check out the list here Read More »

Single-dose of Covishield 61% effective; Revisit vaccination interval with new data: NTAGI chief

New Delhi: A single dose of Covishield is 61% effective over the “Delta” variant, noted Dr NK Arora, who is the expert chair of the National Immunization Technical Advisory Group (NTAGI). On the ongoing debate on the vaccination interval, he said the group would review the new data and make their decision based on it. …

Single-dose of Covishield 61% effective; Revisit vaccination interval with new data: NTAGI chief Read More »

SII CEO Adar Poonawala said that the revised prices of the Covishield vaccine are still only 50% of global rates.

After announcing the prices of the Covishield vaccine for state governments and private hospitals, Serum Institute of India (SII) CEO Adar Poonawala said the new vaccine price is still 33–50 percent of the global vaccine price anywhere in the world . Speaking to CNBC TV-18, Poonawala further said that SII would never take advantage of …

SII CEO Adar Poonawala said that the revised prices of the Covishield vaccine are still only 50% of global rates. Read More »

Omicron Variant: Will virus mutations make vaccines ineffective? Here's what ICMR's Senior Scientist said

Omicron Variant: Will virus mutations make vaccines ineffective? Here’s what ICMR’s Senior Scientist said

New Delhi: Indian Council of Medical Research (ICMR) scientist Samiran Panda on Saturday addressed concerns about Omicron Variant by saying that genomic variations and structural changes have been reported in other countries in the new variant of the coronavirus, but whether these would lead to increased transmission or make ineffective vaccines is under consideration. The …

Omicron Variant: Will virus mutations make vaccines ineffective? Here’s what ICMR’s Senior Scientist said Read More »

Delta OR Delta Plus: which vaccines are effective against new variants of Covid-19

Be it Delta or Delta Plus, none of the variants can pierce the mask, Niti Aayog member (health) VK Paul said. The World Health Organization recently expressed concerns that the Delta variant of Covid-19, the variant first detected in India, was reducing the effectiveness of existing Covid-19 vaccines around the world. A new mutant of …

Delta OR Delta Plus: which vaccines are effective against new variants of Covid-19 Read More »

Study On Mixing Covishield and Covaxin By CMC Vellore Gets DCGI Approval

A study on mixing Covishield and Covaxin, two of the three Covid-19 vaccines currently available in India, has been approved by the Drugs Controller General Of India (DCGI), Niti Aayog member VK Paul said on Tuesday. The study will be conducted by the Christian Medical College (CMC) in Vellore, Tamil Nadu. Paul said at a …

Study On Mixing Covishield and Covaxin By CMC Vellore Gets DCGI Approval Read More »

Scroll to Top